AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 60 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $3,480,000 | +8.2% | 71,609 | +17.0% | 0.01% | +7.7% |
Q2 2017 | $3,217,000 | +36.1% | 61,227 | +17.5% | 0.01% | +30.0% |
Q1 2017 | $2,364,000 | +12.3% | 52,123 | -6.3% | 0.01% | +11.1% |
Q4 2016 | $2,106,000 | -8.8% | 55,653 | -9.0% | 0.01% | -10.0% |
Q3 2016 | $2,308,000 | +65.0% | 61,153 | -23.1% | 0.01% | +66.7% |
Q2 2016 | $1,399,000 | +49.5% | 79,473 | +3.2% | 0.01% | +50.0% |
Q1 2016 | $936,000 | -31.4% | 76,983 | +37.3% | 0.00% | -33.3% |
Q4 2015 | $1,365,000 | +115.0% | 56,078 | +56.6% | 0.01% | +100.0% |
Q3 2015 | $635,000 | +0.5% | 35,813 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $632,000 | -33.3% | 35,813 | +18.4% | 0.00% | -25.0% |
Q1 2015 | $948,000 | +6.6% | 30,239 | -0.7% | 0.00% | 0.0% |
Q4 2014 | $889,000 | +40.7% | 30,451 | -0.2% | 0.00% | +33.3% |
Q3 2014 | $632,000 | -6.5% | 30,524 | +11.9% | 0.00% | 0.0% |
Q2 2014 | $676,000 | +26.6% | 27,286 | +8.3% | 0.00% | +50.0% |
Q1 2014 | $534,000 | +413.5% | 25,193 | +334.7% | 0.00% | – |
Q4 2013 | $104,000 | – | 5,795 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|